Literature DB >> 2943782

Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis.

M E Bertrand, J M LaBlanche, F A Thieuleux, J L Fourrier, G Traisnel, P Asseman.   

Abstract

This study compares the results of percutaneous transluminal coronary angioplasty in a group of 132 patients (group A) with fixed atherosclerotic narrowing (no spontaneous or ergonovine-provoked spasm) and in a group of 97 patients (group B) with dynamic coronary stenosis (spasm superimposed on the stenosis). All these patients underwent complete follow-up angiography. The rate of restenosis (defined as a loss of 50% of the initial gain) was significantly higher in patients in group B (dynamic coronary stenosis) than in group A (fixed narrowing) (35 versus 22%, p less than 0.05). Despite treatment with a calcium antagonist, coronary artery spasm persisted in 44% of the patients in group B and was detected for the first time in 15% of the patients in group A. Thus, in patients with dynamic coronary stenosis, the results of coronary angioplasty were less satisfactory than in patients with fixed narrowing, and in both groups coronary artery spasm was frequently (64%) superimposed on the restenosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943782     DOI: 10.1016/s0735-1097(86)80174-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

2.  Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: results of SHIPS (SHIga Pravastatin Study).

Authors:  Y Nakamura; O Yamaoka; K Uchida; N Morigami; Y Sugimoto; T Fujita; T Inoue; T Fuchi; M Hachisuka; H Ueshima; H Shimakawa; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 3.  A rare indication for stenting: persistent coronary artery spasm.

Authors:  H Kültürsay; L Can; S Payzin; C Türkoğlu; A Altintiğ; M Akin; A Akilli
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

4.  Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

Authors:  E Hoberg; R Dietz; U Frees; H A Katus; B Rauch; A Schömig; G Schuler; F Schwarz; H Tillmanns; J Niebauer
Journal:  Br Heart J       Date:  1994-03

Review 5.  Coronary artery spasm: review and update.

Authors:  Ming-Jui Hung; Patrick Hu; Ming-Yow Hung
Journal:  Int J Med Sci       Date:  2014-08-28       Impact factor: 3.738

6.  Spontaneous Left Main and Right Coronary Artery Spasm in a Patient With Vasospastic Angina.

Authors:  Analkumar Parikh; Thomas Paul Vacek
Journal:  J Investig Med High Impact Case Rep       Date:  2017-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.